Liquidia Technologies Inc. Appoints Dr. Benjamin Yerxa as Chief Scientific Officer

Published: Aug 28, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies, a privately held biotechnology company developing particle-based vaccines and therapeutics, today announced it has named Benjamin Yerxa, Ph.D. as the company’s Chief Scientific Officer. Dr. Yerxa will be responsible for research and development and the overall scientific direction of the company, including a focus on scientific collaborations.

Back to news